Trials / Completed
CompletedNCT02003612
Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia
An Analysis of Historical Data on Hematological Remission and Survival Among Adult Patients With Relapsed / Refractory B-Precursor Acute Lymphoblastic Leukemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,373 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
A retrospective analysis of historical data looking at hematological remission and survival in adult relapsed / refractory B-precursor acute lymphoblastic leukemia patients.
Detailed description
A retrospective observational study reviewing historical survival data (hematological remission and survival) for adult patients who have either relapsed or refractory B-precursor acute lymphoblastic leukemia. Data are aggregated across multiple countries and study sites in the EU and US
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Not applicable - observational study | No intervention exists as this is a retrospective observational study |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-01-10
- Completion
- 2014-04-28
- First posted
- 2013-12-06
- Last updated
- 2022-11-07
Locations
10 sites across 8 countries: United States, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT02003612. Inclusion in this directory is not an endorsement.